Article
A combination of molecular markers and clinical features improve the classification of pancreatic cysts.
Gastroenterology - 1 Nov 2015
Springer Simeon, Wang Yuxuan, Dal Molin Marco, Masica David L, Jiao Yuchen, Kinde Isaac, Blackford Amanda, Raman Siva P, Wolfgang Christopher L, Tomita Tyler, Niknafs Noushin, Douville Christopher, Ptak Janine, Dobbyn Lisa, Allen Peter J, Klimstra David S, Schattner Mark A, Schmidt C Max, Yip-Schneider Michele, Cummings Oscar W, Brand Randall E, Zeh Herbert J, Singhi Aatur D, Scarpa Aldo, Salvia Roberto, Malleo Giuseppe, Zamboni Giuseppe, Falconi Massimo, Jang Jin-Young, Kim Sun-Whe, Kwon Wooil, Hong Seung-Mo, Song Ki-Byung, Kim Song Cheol, Swan Niall, Murphy Jean, Geoghegan Justin, Brugge William, Fernandez-Del Castillo Carlos, Mino-Kenudson Mari, Schulick Richard, Edil Barish H, Adsay Volkan, Paulino Jorge, van Hooft Jeanin, Yachida Shinichi, Nara Satoshi, Hiraoka Nobuyoshi, Yamao Kenji, Hijioka Susuma, van der Merwe Schalk, Goggins Michael, Canto Marcia Irene, Ahuja Nita, Hirose Kenzo, Makary Martin, Weiss Matthew J, Cameron John, Pittman Meredith, Eshleman James R, Diaz Luis A, Papadopoulos Nickolas, Kinzler Kenneth W, Karchin Rachel, Hruban Ralph H, Vogelstein Bert, Lennon Anne Marie
Abstract excerpt
BACKGROUND & AIMS: The management of pancreatic cysts poses challenges to both patients and their physicians. We investigated whether a combination of molecular markers and clinical information could improve the classification of pancreatic cysts and management of patients. METHODS: We performed a multi-center, retrospective study of 130 patients with resected pancreatic cystic neoplasms (12 serous cystadenomas,...
Read the complete abstract on PubMed